Location History:
- Habana, CU (2005)
- Havana, CU (2013)
- Ciudad de la Habana, CU (2014)
Company Filing History:
2 out of 70 
1 out of 15 Years Active: 2005-2014
Title: **Innovative Contributions of Alejandro Miguel Martin Dunn**
Introduction
Alejandro Miguel Martin Dunn is a prolific inventor hailing from Ciudad de la Habana, Cuba. With a total of three patents to his name, his work primarily focuses on developing novel solutions to combat viral infections, particularly those caused by the Flaviviridae family of viruses.
Latest Patents
Among his latest patents, two notable inventions stand out. The first patent, titled "Chimerical Peptidic Molecules with Antiviral Properties Against the Viruses of the Flaviviridae Family," presents a groundbreaking approach to inhibiting the NS3 protease activation in Flaviviridae viruses. This chimerical peptide not only includes segments for viral inhibition but also features a cell-penetrating segment, paving the way for pharmaceutical compounds designed for the prevention and treatment of infections by these viruses.
The second patent, "Method to Block the Infection by Flaviviruses, Molecules and Uses," details a method for preventing the infection of cells by the dengue virus. This method involves disrupting the interaction between the viral envelope protein and the alpha-2 macroglobulin receptor, also known as the low-density receptor-related protein (CD91), utilizing a carrier protein, human alpha-2 macroglobulin.
Career Highlights
Alejandro's notable career includes significant work at renowned institutions focused on genetics and biotechnology, namely the Centro de Ingeniería Genética y Biotecnología. His innovative research has positioned him as a leading figure in the field of antiviral therapies, making strides towards effective treatments for viral diseases.
Collaborations
Throughout his career, Alejandro has collaborated with esteemed colleagues such as Vivian Huerta Galindo and Noralvis Fleitas Salazar. These collaborations have further enhanced his research capabilities, fostering an environment of shared knowledge and progressive discoveries in combating viral infections.
Conclusion
Alejandro Miguel Martin Dunn's contributions to the field of biotechnology and antiviral research exemplify the spirit of innovation. His patents reflect a dedication to developing effective strategies for managing viral infections, underscoring the importance of inventive solutions in the fight against public health challenges.